The Society for Neuroscience is the world’s largest organization of scientists and physicians devoted to understanding the brain and the nervous system. This year the annual SfN meeting will take place in Washington D.C., where thousands of neuroscientists from around the world will meet to debut cutting-edge research on the brain and nervous system.
As a leading CRO in neuropharmacology, Scantox will once again be amongst the exhibitors in Washington D.C. Don’t miss the chance to meet our team of experts there for an introduction to our sophisticated range of validated transgenic and non-transgenic in vivo and in vitro models for neurodegenerative and rare diseases. These include but are not limited to AD, PD, ALS, HD, MS, lysosomal storage diseases like NPC1, MPSs and Gaucher disease, as well as other diseases such as psychosis, anxiety, schizophrenia and autism spectrum disorder.
